Mink Therapeutics
car enhances infiltration of tumor specific cells to clear tumor mink | Mink Therapeutics
Company
Deck Type
Sector
Industry
Deck date
November 2022
Slide
51 of 92
Related slides by other companies
Enochian Biosciences
Investor Presentation
January 2024
| Enochian Biosciences
Alkermes
Investor Day
March 2021
oncology goal activate innate and adaptive immune responses to drive tumor cell death enhanced antigen identification and presentation cell death chemotherapy radiation inhibitors targeted agents growth factor inhibitors immune system activation endogenous other immune cell mediated tumor cell death dendritic cell presenting antigen activated cells and cells activated cells attacking tumor tumor killing and release of antigens cells cells aes | Alkermes
Enochian Biosciences
Investor Presentation
January 2024
| Enochian Biosciences
Immatics
Investor Presentation
November 2023
targeting mechanism of action | Immatics
Other recent decks by Mink Therapeutics
See all presentations (2 decks)
IPO
October 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights